NewsBenzingaPharming reafirma su guía de ventas para el ejercicio fiscal 2026 de $380.000 millones a $390.000 millones frente a los $383.333 millones estimados Pharming reafirma su guía de ventas para el ejercicio fiscal 2026 de $380.000 millones a $390.000 millones frente a los $383.333 millones estimados Benzinga 2026.10.27 08:06 (GMT+0) Open on Benzinga Other news ChargePoint Unveils Channel Partner Program To Help European Resellers Capture Growing Demand For EV Charging Infrastructure Why Is Whirlpool Stock Falling Tuesday? Needham Maintains Buy on Applied Optoelectronics, Lowers Price Target to $170 CenterPoint Energy Q3 Adj. EPS $0.53 Beats $0.49 Estimate, Sales $2.191B Beat $2.173B Estimate Microsoft Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call TransUnion Raises Share Buyback Authorization By $1B To $2B Total
ChargePoint Unveils Channel Partner Program To Help European Resellers Capture Growing Demand For EV Charging Infrastructure
Microsoft Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
